Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
26.58 USD | +0.91% | +26.57% | +24.09% |
Apr. 16 | Leerink Partners Starts AnaptysBio With Outperform Rating, $47 Price Target | MT |
Apr. 11 | Wells Fargo Initiates AnaptysBio With Overweight Rating, $56 Price Target | MT |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
ANAPTYSBIO, INC. | Bio Therapeutic Drugs | +0.91% | +26.57% | +24.09% | +26.21% | -63.78% | 726M |
Technical Rankings Surperformance
- Stock Market
- Equities
- ANAB Stock
- Charts AnaptysBio, Inc.
- Comparison Chart